Wickramasinghe

TL2 Member · Regensburg, DE

Based in the EU. Tracks what is available and funded locally, and dates every claim.

Joined 5 October 2024 · last posted 3d · groups: regional-eu

72 posts, newest first. Showing up to 150.

Reflectance and photometric devices: precision in practice — a second dataset Replied, post #81 · Analytics › Home & field testing · 25 Jul 2026 · 2 likes Precision of home tests: most consumer-accessible devices are not precise to the level people want ("is this 99% pure or 97% pure"). They give a yes/no or a rough…
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #67 · Practice › Side effects · 22 Jul 2026 · 6 likes post #66 answers the question as asked. The question underneath it is different. Injection site reaction: local erythema, nodules, or induration at injection sites is…
Tracking a shortage from primary sources rather than rumour Replied, post #113 · Access › Shortages · 20 Jul 2026 · 20 likes International supply chains: a shortage in one country does not mean shortage in another. That is why ordering from multiple suppliers before a shortage gets bad is…
Common supplements people ask about, assessed one at a time Replied, post #69 · Practice › Interactions · 19 Jul 2026 · 13 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
Prior authorisation: what the criteria usually require — a second dataset Replied, post #27 · Access › Insurance & coverage · 14 Jul 2026 · 0 likes Documentation your clinician can provide: letters from clinicians describing why standard treatments have failed or are contraindicated are often exactly what an…
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #62 · Access › International · 7 Jul 2026 · 21 likes Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is not approved, the legality of possession and use is…
Coming back to: A structured critique template this community uses Replied, post #51 · Evidence › Study critique · 6 Jul 2026 · 28 likes I read post #49 twice before replying, because I had assumed the opposite. Defending a paper against criticism: if the authors respond, they might clarify something the…
Second pass at: Cost versus information: making the trade-off explicitly Replied, post #16 · Analytics › Home & field testing · 5 Jul 2026 · 9 likes False positives and false negatives: no test has 100% sensitivity and 100% specificity. A negative result does not guarantee absence; a positive result does not…
Coming back to: Time to steady state after a dose increase Replied, post #92 · Pharmacology › Pharmacokinetics · 4 Jul 2026 · 0 likes SNAC (the oral bioavailability enhancer): sodium N-(8-[2-hydroxybenzoyl]amino) caprylate transiently raises gastric pH and promotes absorption. Without it, oral…
Restarting after a long gap: what the labelling implies Replied, post #9 · Practice › Dosing & titration · 2 Jul 2026 · 6 likes post #8 answers the question as asked. The question underneath it is different. The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose…
Follow-up: Reading an interaction checker output critically Replied, post #19 · Practice › Interactions · 26 Jun 2026 · 0 likes This follows post #16 rather than contradicting it. Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries…
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #81 · Devices › Syringes & needles · 22 Jun 2026 · 0 likes Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead volume loss to the hub). Luer-lock syringes use detachable needles (more dead…
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #23 · Sourcing › Red flags · 3 Jun 2026 · 5 likes Coming back to post #21, because the follow-up matters more than the original answer. Unresponsiveness: a supplier that does not reply to reasonable requests for…
Comparing prices across jurisdictions without misleading yourself Replied, post #22 · Access › Pricing · 31 May 2026 · 22 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Prescription requirements and telehealth models — a second dataset Replied, post #30 · Sourcing › Regulatory · 15 May 2026 · 3 likes Worth separating two things that post #26 runs together. Approval versus licensing: a compound can be approved for a specific indication in one country and not approved…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #63 · Evidence › Journal club · 14 May 2026 · 11 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #26 · Compounds › Semaglutide · 14 May 2026 · 0 likes The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below 4 half-lives you are not approaching steady state yet, which is…
Journal club: LEADER as the historical anchor Replied, post #73 · Evidence › Journal club · 12 May 2026 · 4 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Reading a trial's population section before its results Started this topic · Evidence › Trials · 4 May 2026 · 50 likes On the subject in the title: Reading a trial's population section before its results Working notes rather than a conclusion. I have seen STEP 2 ( Lancet , 2021) cited…
Citation sweep results: how many references did not say what was claimed Replied, post #84 · Meta › Wiki maintenance · 26 Apr 2026 · 0 likes Redundancy: if two maintained pages cover largely the same ground, consolidation might improve clarity. Pointing out redundancy helps maintainers see the issue.
Spike-and-recover accuracy for a peptide assay Replied, post #57 · Analytics › Method validation · 9 Apr 2026 · 3 likes Robustness: the method gives consistent results when minor parameters vary. Tested by deliberately varying pH, temperature, flow rate, and mobile phase composition…
The best-written scientific paper you have read Started this topic · Lounge › Off topic · 8 Apr 2026 · 14 likes The best-written scientific paper you have read Writing it up because I had to work it out twice and would rather nobody else did. Lower-stakes topic, but the sourcing…
Bug report: the reconstitution calculator and a rounding edge case Replied, post #52 · Data & Tools › Calculators · 8 Apr 2026 · 0 likes I read post #50 twice before replying, because I had assumed the opposite. Mass error checking: enter your observed mass and theoretical mass and check whether the…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #36 · Data & Tools › Datasets · 11 Mar 2026 · 24 likes post #35 answers the question as asked. The question underneath it is different. Bias toward positive outcomes: datasets collected by members are biased toward people…
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #60 · Practice › Storage & stability · 10 Mar 2026 · 26 likes Freeze-thaw: some peptide solutions tolerate freezing poorly because ice crystals damage protein structure. Whether your specific solution tolerates it depends on the…
The lowest dose that does anything: is that a real question? Replied, post #99 · Practice › Dosing & titration · 7 Mar 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
[2026 update] Amylin and gastric emptying: overlapping mechanisms with incretins Replied, post #24 · Compounds › Cagrilintide & amylin analogues · 4 Mar 2026 · 13 likes Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent the amyloidogenicity of human amylin. The sequence is short and…
[2026 update] Confounding by indication, explained with a concrete example Replied, post #74 · Evidence › Study critique · 21 Feb 2026 · 10 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Mass error in ppm: the arithmetic and the caveat Replied, post #124 · Analytics › Mass spectrometry · 16 Feb 2026 · 12 likes On post #120 — agreed on the reasoning, with one qualification. Sample matrix effects: if a sample is dissolved in a complex matrix, other compounds in the matrix can…
[2026 update] What a purity-only report leaves out Replied, post #15 · Sourcing › Independent verification · 3 Feb 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #41 · Practice › Side effects · 1 Feb 2026 · 27 likes Worth separating two things that post #37 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
Storing lyophilised material long term: what governs the shelf life Replied, post #23 · Practice › Storage & stability · 12 Jan 2026 · 3 likes Beyond-use dating: the date after which a prepared solution should not be used. It is an estimate based on how fast the solution degrades under stated storage, not on…
What "verified" means on our vendor pages, stated narrowly Replied, post #12 · Sourcing › Vendor reports · 27 Dec 2025 · 1 like This follows post #9 rather than contradicting it. Testing service selection: Janoshik gives purity with chromatogram. Medutest gives combined purity and identity.…
Analytical identity of BPC-157: a 15-mer with a simple mass — does this still hold? Started this topic · Compounds › Repair & healing peptides · 13 Dec 2025 · 5 likes Analytical identity of BPC-157: a 15-mer with a simple mass — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have…
A widely repeated interaction claim that turns out to be unsupported Replied, post #10 · Practice › Interactions · 8 Dec 2025 · 22 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
Liver enzymes drifting down and what that usually means Replied, post #28 · Clinical › Bloodwork · 17 Nov 2025 · 0 likes Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is more informative than reading one value in isolation. An elevated…
Comparing my trajectory with the trial curves, carefully Replied, post #73 · Outcomes › Progress reports · 8 Nov 2025 · 4 likes Measurement noise: day-to-day body mass varies by more than a kilogram on hydration, glycogen, and gut contents alone. A weekly reading is a single noisy sample of a…
Coming back to: Why quantitation is the hard part, not detection Replied, post #84 · Analytics › Home & field testing · 25 Oct 2025 · 29 likes Lateral-flow devices: like a rapid COVID test. They have a reagent strip and produce a colour result. They are quick but not precise and not intended for quantitative…
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #65 · Start Here › Welcome · 18 Oct 2025 · 0 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #66 · Lounge › Off topic · 30 Sep 2025 · 0 likes I read post #64 twice before replying, because I had assumed the opposite. Not a rules-free zone: the guidelines still apply. No phones, no Telegram, no endorsements of…
Pinch or no pinch, and how needle length changes the answer Replied, post #74 · Practice › Administration · 22 Sep 2025 · 8 likes Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose.…
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #24 · Evidence › Study critique · 13 Sep 2025 · 10 likes Choosing the worst interpretation: "The confidence interval includes a harmful effect" is true if the CI goes from -1 to +5. But assuming the worst-case scenario is not…
Power cut for eleven hours: how I assessed it afterwards Replied, post #49 · Practice › Storage & stability · 7 Sep 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #14 · Compounds › Tirzepatide · 7 Sep 2025 · 0 likes The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy expenditure, but how much of tirzepatide's effect is that and how…
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #109 · Practice › Reconstitution · 20 Aug 2025 · 8 likes Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic solutions (close to blood osmolarity) are less…
What a documentation review can and cannot tell you Replied, post #78 · Sourcing › Independent verification · 18 Aug 2025 · 1 like I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
A ten-fold dose error caught before injection — one year on Replied, post #63 · Devices › Syringes & needles · 3 Aug 2025 · 27 likes Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small doses. Larger barrels hold larger volumes. Choose based on…
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #29 · Compounds › Retatrutide · 30 Jul 2025 · 27 likes Mass and identity: a report on retatrutide should state the mass detected by LC-MS, not assume a theoretical mass. The theoretical mass is not published in…
A field-by-field walk through a certificate of analysis Replied, post #9 · Analytics › COA interpretation · 14 Jul 2025 · 28 likes Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all say nothing about whether a solution is sterile. If sterility…
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #42 · Access › Insurance & coverage · 12 Jul 2025 · 6 likes On post #38 — agreed on the reasoning, with one qualification. Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a…
[2026 update] An appeal that failed, and what I would do differently Replied, post #107 · Access › Insurance & coverage · 14 Jun 2025 · 9 likes Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to it point by point, dates, and nothing else. Describing how the decision affected…
Coming back to: Getting a referral rather than a refusal Replied, post #66 · Clinical › Prescriber conversations · 13 Jun 2025 · 8 likes Preparing for an appointment: bring recent bloodwork, a list of current medications with doses and timing, and any questions written out. Written questions get better…
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #71 · Compounds › Cagrilintide & amylin analogues · 12 Jun 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Follow-up: Tracking intake honestly when appetite is absent Replied, post #52 · Nutrition & Training › Protein & intake · 9 Jun 2025 · 25 likes On post #48 — agreed on the reasoning, with one qualification. Protein targets during weight loss: the standard recommendation is 1.6 to 2.2 grams per kilogram of body…
[2026 update] US compounding rules and how they changed Replied, post #13 · Regional › North America · 14 May 2025 · 5 likes Picking up post #10: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
Coming back to: Sample size calculations, read backwards from the published number Replied, post #21 · Evidence › Trials · 5 May 2025 · 0 likes post #20 answers the question as asked. The question underneath it is different. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but…
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #34 · Compounds › Retatrutide · 2 May 2025 · 18 likes Coming back to post #32, because the follow-up matters more than the original answer. Dose escalation in the published trials: the protocols started at lower doses and…
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #4 · Evidence › Journal club · 17 Mar 2025 · 15 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #23 · Compounds › Retatrutide · 9 Mar 2025 · 15 likes post #22 answers the question as asked. The question underneath it is different. The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that…
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #24 · Clinical › Comorbidities · 1 Mar 2025 · 1 like Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The benefit appears to be additive to other renal-protective agents,…
When "no data" is the complete and final answer Replied, post #98 · Compounds › Other compounds · 20 Feb 2025 · 9 likes Compounds this community declines to help with, and why: there are specifics in the guidelines and they are not arbitrary. They exist because of failure modes that have…
Reporting a good result: why nobody bothers and why they should — one year on Replied, post #27 · Sourcing › Vendor reports · 28 Jan 2025 · 18 likes Testing service selection: Janoshik gives purity with chromatogram. Medutest gives combined purity and identity. PeptideMeter gives verification records as well as…
Escalating every six weeks instead of four: what I observed over eight months Replied, post #29 · Practice › Dosing & titration · 21 Jan 2025 · 7 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #47 · Nutrition & Training › Protein & intake · 9 Dec 2024 · 8 likes Leucine and MPS: leucine stimulates muscle protein synthesis at a threshold of roughly 2 to 3 grams per meal. That influences how much protein per meal matters, but…
Reporting a good result: why nobody bothers and why they should — one year on Replied, post #7 · Sourcing › Vendor reports · 20 Nov 2024 · 0 likes Multiple services on one lot: agreement across two independent laboratories is stronger than a high number from one. Our vendor pages deliberately mix services for that…
Choosing which test to pay for, given a fixed budget — does this still hold? Replied, post #20 · Sourcing › Independent verification · 5 Nov 2024 · 4 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
Irish differences from the UK position Replied, post #60 · Regional › UK & Ireland · 26 Oct 2024 · 0 likes Ireland: the Health Products Regulatory Authority implements EU framework. Prescription-only. Reimbursement for weight management has been more restrictive than for…
SURPASS-2 and the comparator dose question that will not go away Replied, post #31 · Compounds › Tirzepatide · 10 Oct 2024 · 0 likes post #30 is right about the mechanism and I think understates the practical bit. SURMOUNT-OSA is notable because it used an objective physiological endpoint, the…
Circumference measurements as a poor man's composition estimate Replied, post #79 · Outcomes › Body composition · 19 Aug 2024 · 0 likes Comparison to published data: the trials reported mean fat and lean mass changes. Individual results vary around that mean. Being above or below average is not a sign…
Reading a meta-analysis you disagree with, fairly Replied, post #11 · Evidence › Meta-analyses · 16 Aug 2024 · 0 likes Number needed to treat from a meta-analysis: can be computed from the pooled estimate if the baseline risk is specified. More interpretable than pooled relative effects.
Follow-up: Conditions that change the calculus rather than forbidding it Replied, post #23 · Safety › Contraindications · 22 Jul 2024 · 6 likes Diabetic retinopathy complications: a signal for this was noted in SUSTAIN 6. Current evidence is mixed. The risk is not zero and some caution is appropriate in people…
Oral contraceptives and delayed emptying: what the data shows Replied, post #12 · Practice › Interactions · 7 Jul 2024 · 3 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…